Home
low estrogen and vertigo
Frontiers Effect of the serum 25-hydroxyvitamin D level on risk for short-term residual dizziness after successful repositioning in benign paroxysmal positional vertigo stratified by sex and onset age

Frontiers Effect of the serum 25-hydroxyvitamin D level on risk for short-term residual dizziness after successful repositioning in benign paroxysmal positional vertigo stratified by sex and onset age

4.9 (457) · $ 8.00 · In stock

ObjectiveA low serum 25-hydroxyvitamin D (25(OH)D) level is relevant to both the occurrence and recurrence of benign paroxysmal positional vertigo (BPPV). Ho

Continuum - Key Points (All Topics), PDF, Autonomic Nervous System

PDF) The relationship between psychological conditions and recurrence of benign paroxysmal positional vertigo: a retrospective cohort study

medical-acronyms

Chemiluminescence immunoassay - List of Frontiers' open access articles

PDF) Prevention of recurrent benign paroxysmal positional vertigo with vitamin D supplementation: a meta-analysis

Frontiers Effect of the serum 25-hydroxyvitamin D level on risk for short-term residual dizziness after successful repositioning in benign paroxysmal positional vertigo stratified by sex and onset age

Frontiers in Neurology Neurological Biomarkers

Seasonal variability of serum 25-hydroxyvitamin D on multiple sclerosis onset

JaypeeDigital

Serum 25-hydroxyvitamin D - List of Frontiers' open access articles

Association of serum 25-hydroxyvitamin d concentrations with all-cause and cause-specific mortality among individuals with depression: A cohort study - ScienceDirect

Frontiers Correlation Between Benign Paroxysmal Positional Vertigo and 25-hydroxyvitamin D